Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Currently, Retatrutide is in Phase 3 clinical trials , with approval from regulatory agencies like the MHRA and EMA likely to occur in the coming years
The key findings from this clinical program include significant reductions in body weight and fat mass in treatment groups compared to placebo, preferential loss of abdominal and visceral adipose tissue, no changes in serum IGF-1 levels at any dose tested, no negative effects on glucose metabolism or insulin sensitivity, no significant adverse events related to metabolic or endocrine disruption, and safety profile indistinguishable from placebo for most parameters
Manufactured to the highest quality standards, ensuring purity, potency, and efficacy
All other data supporting the findings of this study are available within the article and its Supplementary Information
The source of the L-cysteine and of the stearic acid is not stated on the label and is currently unconfirmed
US$ 22.35
US$ 22.05
US$ 28.53
US$ 28.82
US$ 29.31
US$ 29.00
US$ 20.84
US$ 21.79
US$ 25.58
